Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005908
Filing Date
2025-08-15
Accepted
2025-08-15 16:26:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3241
  Complete submission text file 0001950047-25-005908.txt   5153
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-31812 | Film No.: 251225030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AMPERSAND CAPITAL PARTNERS ONE POST OFFICE SQUARE, SUITE 2900 BOSTON MA 02109
Business Address AMPERSAND CAPITAL PARTNERS ONE POST OFFICE SQUARE, SUITE 2900 BOSTON MA 02109 781-239-0700
Ampersand 2020 Limited Partnership (Reporting) CIK: 0001806621 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144